e58b67eb1f3dd44598e3ee9686c30d3f

CENTERPIECE® PLATE FIXATION SYSTEM- SISTEMA DE FIJACION DE LAMINOPLASTIA Y SU INSTRUMENTAL ASOCIADO

CENTERPIECE® PLATE FIXATION SYSTEM
MEDTRONIC INC·III·Colombia INVIMA·Expires April 03, 2034
Device classification
Risk class / Clase de Riesgo
III
Product type (Spanish)
MEDICO QUIRURGICOS
Product type (English)
SURGICAL DOCTOR
Registration information
Analysis ID
e58b67eb1f3dd44598e3ee9686c30d3f
Expire date
April 03, 2034
Authorized company / Fabricante
Name (Spanish)
MEDTRONIC INC
Name (English)
MEDTRONIC INC
Product use / Uso del Producto
Spanish

EL SISTEMA DE FIJACIÓN DE PLACA CENTERPIECE™ DE MEDTRONIC SOFAMOR ESTÁ INDICADO PARA SU USO EN LA COLUMNA CERVICAL INFERIOR Y TORÁCICA SUPERIOR (C3 A T3) EN INTERVENCIONES DE LAMINOPLASTIA. EL SISTEMA DE FIJACIÓN DE PLACA CENTERPIECE™ SE USA PARA FIJAR EL MATERIAL DEL INJERTO CON EL FIN DE EVITAR QUE ESTE SE EXPULSE O TOQUE LA MÉDULA ESPINAL.

English

THE CENTERPIECE™ PLATE FIXATION SYSTEM FROM MEDTRONIC SOFAMOR IS INDICATED FOR USE ON THE LOWER CERVICAL AND UPPER THORACIC SPINE (C3 TO T3) IN LAMINOPLASTY PROCEDURES. THE CENTERPIECE™ PLATE FIXATION SYSTEM IS USED TO FIX THE GRAFT MATERIAL TO PREVENT IT FROM BEING EJECTED OR TOUCHING THE SPINAL CORD.

About this record

Access comprehensive regulatory information for CENTERPIECE® PLATE FIXATION SYSTEM- SISTEMA DE FIJACION DE LAMINOPLASTIA Y SU INSTRUMENTAL ASOCIADO (CENTERPIECE® PLATE FIXATION SYSTEM) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID e58b67eb1f3dd44598e3ee9686c30d3f and manufactured by MEDTRONIC INC. The device was registered on April 03, 2034.

This page provides complete registration details including product type (SURGICAL DOCTOR), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.